Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atenolol vs Propranolol for Infantile Hemangiomas
NCT03237637Phase 3Unknown
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Mar 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atenolol in infantile hemangioma (IH), sponsored by Post Graduate Institute of Medical Education and Research. Status: unknown.
02
Drugs
atenolol
03
Conditions
infantile hemangioma (IH)
Beyond the preview
Go deeper on NCT03237637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03237637.